Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Wednesday, January 05, 2022
Emmes, a global, full-service Clinical Research Organization (CRO) announced that it has acquired Institut Dr. Schauerte, a CRO headquartered in Munich, Germany. Founded in 1990, Institut Dr. Schauerte is a full-service, technology-oriented CRO that ...
read more
Wednesday, January 05, 2022
Altasciences, an integrated CRO/CDMO has completed the acquisition of Sinclair Research, a preclinical CRO located in the Midwest. Complementing existing locations on the East and West Coast, the new site will facilitate even greater access to ...
read more
Wednesday, January 05, 2022
Piramal Pharma Limited’s Pharma Solutions (PPS) business, a Contract Research, Development and Manufacturing Organization (CDMO), announced that the company has made a multi-million-dollar investment to create a world-class high-throughput screening ...
read more
Thursday, January 06, 2022
Wheeler Bio, a biomanufacturing company built to accelerate the translation of therapeutic innovation into clinical impact, announced today the closing of a $14M Seed financing round.
read more
Catalent announced that its Board of Directors has appointed Alessandro Maselli, currently President and Chief Operating Officer, as the company’s next President and Chief Executive Officer, effective July 1, 2022.
read more
Research Triangle Park, N.C.-based CATO SMS and Bracknell, U.K.-headquartered Pharm-Olam, both providers of specialized clinical research services, announced today that they are merging to form a leading global biopharmaceutical services organization...
read more
Your input is important as we benchmark current global and regional trends affecting the bioindustry. You will receive, a FREE Aggregated Summary of the results of this important global study, a FREE White Paper - Top Trends in Biopharmaceutical ...
read more
Tuesday, January 11, 2022
Avid Bioservices, Inc. announced the official opening of the second downstream processing suite within the company’s existing Myford North facility.
read more
Tuesday, January 11, 2022
Recipharm announced the sale to Astrea Pharma, the newly established CDMO provider focused on small molecule oral solid and aseptic dosages, of the solid dose manufacturing site at Fontaine-lès-Dijon, France.
read more
Tuesday, January 11, 2022
Pharmaron acquires commercial API manufacturing facility in the United Kingdom from Recipharm, and continues to strengthen the global chemistry and manufacturing capabilities and capacities.
read more
Wednesday, January 12, 2022
Performance Cell Manufacturing a contract development and manufacturing organization announced that it has been acquired by Great Point Partners (“GPP”), a Greenwich, Connecticut based private investment firm focused on the healthcare industry.
read more
Wednesday, January 12, 2022
Malvern Panalytical announced its acquisition of Creoptix AG, a specialist bioanalysis sensor company.
read more
Wednesday, January 12, 2022
Catalent has increased cold chain packaging capabilities at its Philadelphia facility to support increased demand for the distribution of biologic drugs, and advanced cell and gene therapies.
read more
Wednesday, January 12, 2022
Sinocompound Catalysts Co., Ltd has partnered with InCatT to launch a specialist Catalyst Screening Service for pharmaceutical, and fine chemical companies looking to optimize their reactions.
read more
Thursday, January 13, 2022
Procaps Group announced the closing of an asset purchase agreement to acquire an 86,000 sq. ft. pharmaceutical production facility located in Florida with production capacity of approximately 1.8 billion capsules per year.
read more